Watchlist Price Alert

ACADIA Pharmaceuticals In... (ACAD)

NASDAQ: ACAD · Real-Time Price · USD

17.36

0.20 (1.17%)

At close: May 15, 2025, 1:48 PM

ACADIA Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	319.59M	188.66M	114.85M	147.44M	326.03M	189.68M	134.76M	69.42M	163.62M
Short-Term Investments	436.4M	250.21M	301.98M	373.27M	305.93M	507.75M	338.76M	271.92M	365.42M
Long-Term Investments	n/a	5.77M	12.97M	9.37M	7.07M	7.09M	4.83M	2.48M	2.38M
Other Long-Term Assets	78.87M	5.1M	5.31M	6.61M	7.45M	7.64M	6.72M	2.83M	3.16M
Receivables	104.69M	102.35M	63.08M	65.34M	50.28M	37.87M	27.79M	18.43M	7.14M
Inventory	21.95M	35.82M	6.64M	7.88M	9.68M	6.34M	4.07M	5.25M	4.17M
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	938.32M	616.13M	507.94M	617.82M	717.62M	760.25M	526.11M	373.48M	547.9M
Property-Plant & Equipment	50.79M	56.47M	61.59M	66.31M	56.44M	12.7M	3.31M	2.66M	3.08M
Goodwill & Intangibles	119.78M	65.49M	n/a	n/a	1.11M	2.58M	4.06M	5.54M	7.01M
Total Long-Term Assets	249.44M	132.83M	79.88M	82.3M	65M	22.93M	14.1M	11.03M	13.26M
Total Assets	1.19B	748.96M	587.81M	700.12M	782.62M	783.18M	540.2M	384.51M	561.15M
Account Payables	16.19M	17.54M	12.75M	6.88M	8.49M	7.22M	3.17M	8.79M	3.91M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.64M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	171.87M	92.31M	49.51M	39.27M	52.46M	31.76M	33.52M	21.39M	21.65M
Total Current Liabilities	394.87M	254.25M	125.63M	96.07M	105.97M	74.83M	59.56M	49.03M	42.59M
Long-Term Debt	n/a	n/a	n/a	56.13M	44.46M	6.36M	n/a	n/a	n/a
Other Long-Term Liabilities	18.06M	15.15M	9.07M	-49.09M	-39.28M	-3.5M	1.56M	191K	157K
Total Long-Term Liabilities	60.09M	62.95M	61.77M	63.16M	49.64M	9.22M	1.56M	191K	157K
Total Liabilities	454.96M	317.2M	187.4M	159.23M	155.61M	84.05M	61.12M	49.22M	42.74M
Total Debt	51.99M	57.2M	62M	56.13M	44.46M	6.36M	n/a	n/a	n/a
Common Stock	16K	16K	16K	16K	16K	15K	14K	12K	12K
Retained Earnings	-2.2B	-2.43B	-2.37B	-2.15B	-1.99B	-1.7B	-1.47B	-1.22B	-933.98M
Comprehensive Income	292K	24K	-975K	-192K	36K	297K	-372K	-399K	106K
Shareholders Equity	732.79M	431.75M	400.41M	540.89M	627.01M	699.13M	479.08M	335.29M	518.41M
Total Investments	436.4M	255.98M	301.98M	373.27M	305.93M	507.75M	338.76M	271.92M	365.42M